Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
NuCana BioMed
1316
NuCana BioMed
Technology
Biotechnology
A clinical stage biopharmaceutical company transforming anti-cancer agents into better and safer medicines that overcome key resistance mechanisms
Suggest edits
Type
B2c
Founded
2008
Raised
$167.5M
Follow us
Also headquartered in Edinburgh
FCA
Skyscanner
Rockstar Games
Tesco Bank
The Royal Bank of Scotland
Bank of Scotland
Legalesign
BLACKBX
Baillie Gifford
Skyrora
Companies in the same industry
Charles River Labs
BioVex
Third Wave Technologies
enEvolv
Kythera Biopharma
SA Ignite
Wellpepper
FibroGen
Promethera Biosciences
Nirmidas Biotech
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$100,000,000
Post-IPO equity - 2017
$57,000,000
Venture capital (Series B) - 2014
Team Size
2
Employees
I work here
Location
Edinburgh
,
United Kingdom
Headquarters
Explore Edinburgh
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when NuCana BioMed makes some noise.